
Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month international multi-center phase 3 trial
Gordon K. Wilcock, Sandra E. Black, Alfred H. Balch, David A. Amato, Andrew P. Beelen, Lon S. Schneider, Robert C. Green, Edward A. Swabb, Kenton H. ZavitzVolume:
5
Année:
2009
Langue:
english
DOI:
10.1016/j.jalz.2009.05.220
Fichier:
PDF, 121 KB
english, 2009